CHRS vs. AMKR
CHRS (Coherus BioSciences, Inc.) and AMKR (Amkor Technology, Inc.) are both stocks. CHRS operates in Biotechnology (Healthcare), while AMKR operates in Semiconductors (Technology). Over the past 10 years, CHRS returned -24.24%/yr vs 27.67%/yr for AMKR. At a 0.27 correlation, their price movements are largely independent.
Performance
CHRS vs. AMKR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CHRS achieves a 3.52% return, which is significantly lower than AMKR's 67.83% return. Over the past 10 years, CHRS has underperformed AMKR with an annualized return of -24.24%, while AMKR has yielded a comparatively higher 27.67% annualized return.
CHRS
- 1D
- -4.55%
- 1M
- 5.00%
- 6M
- -10.91%
- YTD
- 3.52%
- 1Y
- 67.05%
- 3Y*
- -28.73%
- 5Y*
- -35.47%
- 10Y*
- -24.24%
AMKR
- 1D
- -6.26%
- 1M
- -20.20%
- 6M
- 28.46%
- YTD
- 67.83%
- 1Y
- 204.79%
- 3Y*
- 33.39%
- 5Y*
- 25.43%
- 10Y*
- 27.67%
CHRS vs. AMKR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CHRS Coherus BioSciences, Inc. | 3.52% | 2.90% | -58.56% | -57.95% | -50.38% | -8.17% | -3.47% | 98.95% | 2.84% | -68.74% |
AMKR Amkor Technology, Inc. | 67.83% | 55.87% | -20.80% | 40.32% | -2.31% | 65.57% | 16.30% | 98.17% | -34.73% | -4.74% |
Correlation
The correlation between CHRS and AMKR is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Nov 6, 2014 | 0.27 |
Fundamentals
CHRS:
$179.94M
AMKR:
$16.37B
CHRS:
$1.50
AMKR:
$2.63
CHRS:
0.98
AMKR:
25.07
CHRS:
3.90
AMKR:
1.55
CHRS:
$46.88M
AMKR:
$7.07B
CHRS:
$23.41M
AMKR:
$1.02B
CHRS:
-$162.15M
AMKR:
$1.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CHRS vs. AMKR — Risk / Return Rank
CHRS
AMKR
CHRS vs. AMKR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coherus BioSciences, Inc. (CHRS) and Amkor Technology, Inc. (AMKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CHRS | AMKR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.39 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.47 | 6.83 | -5.36 |
| Martin ratioReturn relative to average drawdown | 2.60 | 19.10 | -16.49 |
Loading charts...
Drawdowns
CHRS vs. AMKR - Drawdown Comparison
The maximum CHRS drawdown since its inception was -98.21%, roughly equal to the maximum AMKR drawdown of -98.14%. Use the drawdown chart below to compare losses from any high point for CHRS and AMKR.
Loading charts...
Drawdown Indicators
| CHRS | AMKR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.21% | -98.14% | -0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -45.82% | -30.17% | -15.65% |
Max Drawdown (3Y)Largest decline over 3 years | -87.71% | -65.86% | -21.85% |
Max Drawdown (5Y)Largest decline over 5 years | -96.47% | -65.86% | -30.61% |
Max Drawdown (10Y)Largest decline over 10 years | -97.88% | -65.86% | -32.02% |
Current DrawdownCurrent decline from peak | -96.08% | -29.39% | -66.69% |
Average DrawdownAverage peak-to-trough decline | -63.75% | -75.61% | +11.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.84% | 10.78% | +15.06% |
Volatility
CHRS vs. AMKR - Volatility Comparison
The current volatility for Coherus BioSciences, Inc. (CHRS) is 17.27%, while Amkor Technology, Inc. (AMKR) has a volatility of 28.97%. This indicates that CHRS experiences smaller price fluctuations and is considered to be less risky than AMKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CHRS | AMKR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.27% | 28.97% | -11.70% |
Volatility (6M)Calculated over the trailing 6-month period | 59.75% | 54.80% | +4.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.44% | 71.01% | +10.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 84.98% | 53.57% | +31.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.40% | 53.48% | +20.92% |
Dividends
CHRS vs. AMKR - Dividend Comparison
CHRS has not paid dividends to shareholders, while AMKR's dividend yield for the trailing twelve months is around 0.50%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
AMKR Amkor Technology, Inc. | 0.50% | 0.84% | 2.82% | 0.91% | 0.94% | 0.69% | 0.27% |
CHRS Coherus BioSciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CHRS vs. AMKR - Financials Comparison
This section allows you to compare key financial metrics between Coherus BioSciences, Inc. and Amkor Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CHRS and AMKR have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMKR has higher volatility (28.97%) compared to CHRS (17.27%). In terms of maximum drawdown, CHRS dropped -98.21% vs AMKR's -98.14%.
AMKR currently has the higher Sharpe Ratio (2.91 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CHRS and AMKR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer